FDA approves updated COVID-19 vaccines for 2026-27 season
The Food and Drug Administration has approved updated COVID-19 vaccines from Moderna, Pfizer-BioNTech and Novavax-Sanofi for the 2026-27 immunization season, with the shots designed to target the XFG variant, the companies announced Thursday.